Zobrazeno 1 - 10
of 275
pro vyhledávání: '"Paul E. De Jong"'
Predictors of progression in albuminuria in the general population: results from the PREVEND cohort.
Autor:
Lieneke Scheven, Nynke Halbesma, Paul E de Jong, Dick de Zeeuw, Stephan J L Bakker, Ron T Gansevoort
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e61119 (2013)
BACKGROUND: Urinary albumin excretion is known to be independently associated with progression of renal and cardiovascular disease. The aim of this study was to identify predictors for progression in albuminuria in the general population. METHODS: Da
Externí odkaz:
https://doaj.org/article/a2b07923fd824c83a7627c0cc234ad45
Autor:
Stephan J. L. Bakker, Sipke T. Visser, Paul E. de Jong, Chris H. L. Thio, Akin Ozyilmaz, Ron T. Gansevoort
Publikováno v:
Nephrology, Dialysis, Transplantation, 32(2), 200-208. Oxford University Press
Background. We investigated whether initial population screening for elevated albuminuria with subsequent screening for hypertension in case albuminuria is elevated may be of help to identify subjects at risk for accelerated decline in kidney functio
Autor:
Hiddo J L Heerspink, Tom Greene, Hocine Tighiouart, Ron T Gansevoort, Josef Coresh, Andrew L Simon, Tak Mao Chan, Fan Fan Hou, Julia B Lewis, Francesco Locatelli, Manuel Praga, Francesco Paolo Schena, Andrew S Levey, Lesley A Inker, Angel Sevillano, Anne-Lise Kamper, Arjan D. van Zuilen, Barry M. Brenner, Bart Maes, Benno U. Ihle, Brendan Barret, CB Leung, CC Szeto, Christina Fitzner, Christoph Wanner, Claudio Pozzi, Claudio Ponticelli Montagnino, Di Xie, Dick de Zeeuw, Edmund Lewis, Eduardo Verde, Eduardo Gutierrez, Enyu Imai, Fernando Caravaca, Fernando C. Fervenza, Fumiaki Kobayashi, Gabriella Moroni, Gavin J. Becker, Gerald J. Beck, Gerald B. Appel, Gershon Frisch, GG van Essen, Giuseppe Maschio, Giuseppe Remuzzi, Giuseppe Montogrino, Hans-Henrik Parving, Hiddo J.L. Heerspink, Hirofumi Makino, Imitiaz Jehan, Jack F.M. Wetzels, James Donadio, Jamie Dwyer, Jan van den Brand, John Kusek, John M. Lachin, Jose Luño, Julia B. Lewis, Jürgen Floege, Kaleab Z. Abebe, KM Chow, Lawrence G. Hunsicker, Lucia del Vecchio, Manno Carlo, Marian Goicoechea, Maximilian von Eynatten, Neil Poulter, Nish Chaturvedi, Patrizia Passerini, Paul E. de Jong, Peter J. Blankestijn, Philip Li, Piero Ruggenenti, Pietro Zucchelli, Priscilla S. Kincaid-Smith, Ralf-Dieter Hilgers, Raymond O. Estacio, Richard D. Rohde, Ritsuko Katafuchi, Robert D. Toto, Robert W. Schrier, Roger A. Rodby, Ronald D. Perrone, Sadayoshi Ito, Saulo Klahr, Simeone Andrulli, Svend Strandgaard, Thierry P. Hannedouche, Thomas Rauen, Ursula Verdalles, Vlado Perkovic, William Keane
Publikováno v:
Lancet Diabetes & Endocrinology, 7, 128-139
Lancet Diabetes & Endocrinology, 7(2), 128-139. ELSEVIER SCIENCE INC
The Lancet Diabetes and Endocrinology, 7(2), 128. Elsevier BV
Lancet Diabetes & Endocrinology, 7, 2, pp. 128-139
Lancet Diabetes & Endocrinology, 7(2), 128-139. ELSEVIER SCIENCE INC
The Lancet Diabetes and Endocrinology, 7(2), 128. Elsevier BV
Lancet Diabetes & Endocrinology, 7, 2, pp. 128-139
Background Change in albuminuria has strong biological plausibility as a surrogate endpoint for progression of chronic kidney disease, but empirical evidence to support its validity is lacking. We aimed to determine the association between treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3713b31bfb274314279f02c21f27d8f8
http://hdl.handle.net/2066/202989
http://hdl.handle.net/2066/202989
Autor:
Morgan E. Grams, Yingying Sang, Shoshana H. Ballew, Ron T. Gansevoort, Heejin Kimm, Csaba P. Kovesdy, David Naimark, Cecilia Oien, David H. Smith, Josef Coresh, Mark J. Sarnak, Benedicte Stengel, Marcello Tonelli, Brenda R. Hemmelgarn, Matthew T. James, Tanvir Chowdhury Turin, Kunihiro Matsushita, Morgan Grams, Michael Shlipak, Ronit Katz, David C. Wheeler, Jonathan Emberson, Martin J. Landray, Jonathan N. Townend, Jamie Green, H. Les Kirchner, Robert Perkins, Alex R. Chang, Solfrid Romundstad, Knut Aasarød, Cecilia M. Øien, Stein Hallan, Micah L. Thorp, Eric S. Johnson, Gabriel Chodick, Esma Herzel, Rachel Katz, Varda Shalev, Stephan J.L. Bakker, Hiddo J. Lambers Heerspink, Pim van der Harst, Sun Ha Jee, Yejin Mok, Navdeep Tangri, Johan Ärnlöv, Anders Larsson, Lars Lannfelt, Kamyar Kalantar-Zadeh, Paul E. de Jong, Kunitoshi Iseki, Andrew S. Levey, David Warnock, Mark Woodward
Publikováno v:
American Journal of Kidney Diseases, 66(4), 591-601. W B SAUNDERS CO-ELSEVIER INC
Background: Acute kidney injury (AKI) is a serious global public health problem. We aimed to quantify the risk of AKI associated with estimated glomerular filtration rate (eGFR), albuminuria (albumin-creatinine ratio [ACR]), age, sex, and race (Afric
Autor:
Peter Kappert, Holly B. Krasa, Dorothee Oberdhan, John Ouyang, Paul E. de Jong, Wendy E. Boertien, Frank S. Czerwiec, Remco J. Renken, Esther Meijer, Gert J. Ter Horst, Eric J. van der Jagt, Joachim Struck, Gerwin E. Engels, Ron T. Gansevoort, Willem van Oeveren
Publikováno v:
American Journal of Kidney Diseases, 65(6), 833-841. W B SAUNDERS CO-ELSEVIER INC
Background: A recent study showed that tolvaptan, a vasopressin V-2 receptor antagonist, decreased total kidney volume (TKV) growth and estimated glomerular filtration rate (GFR) loss in autosomal dominant polycystic kidney disease (ADPKD) with creat
Autor:
Wendy E. Boertien, Gerjan Navis, Esther Meijer, Casper F. M. Franssen, Else van den Berg, Anneke C. Muller Kobold, Ron T. Gansevoort, Debbie Zittema, Stephan J. L. Bakker, Paul E. de Jong
Publikováno v:
Journal of the American Society of Nephrology, 9(9), 1553-1562. AMER SOC NEPHROLOGY
Plasma copeptin, a marker of arginine vasopressin, is elevated in patients with autosomal dominant polycystic kidney disease and predicts disease progression. It is unknown whether elevated copeptin levels result from decreased kidney clearance or as
Autor:
Anneke C. Muller Kobold, Adriaan A. Voors, Stephan J. L. Bakker, Johanna Kuipers, Wim van Oeveren, Casper F. M. Franssen, Paul E. de Jong, Ralf Westerhuis, Yoran M. Hummel, Joachim Struck, Solmaz Assa, Henk Groen
Publikováno v:
American Journal of Kidney Diseases, 64(2), 265-273. W B SAUNDERS CO-ELSEVIER INC
Background: Hemodialysis may acutely induce regional left ventricular (LV) systolic dysfunction, which is associated with increased mortality and progressive heart failure. We tested the hypothesis that hemodialysis-induced regional LV systolic dysfu
Autor:
Priya Vart, Esmee M. Ettema, Ron T. Gansevoort, Johanna Kuipers, Debbie Zittema, Ralf Westerhuis, Paul E. de Jong, Casper F. M. Franssen
Publikováno v:
American Journal of Nephrology. 39(2):100-109
Background: Intradialytic hypotension is a common complication of hemodialysis (HD). Some studies have suggested that inadequate arginine vasopressin (AVP) increase could play a role in the pathogenesis of intradialytic hypotension. However, AVP leve
Autor:
Judith J. Dasselaar, Paul E. de Jong, Len A. Usvyat, Jurjen K. Oosterhuis, Casper F. M. Franssen, Ralf Westerhuis, Peter Kotanko, Johanna Kuipers, Yuedong Wang, Jeffrey J. Sands
Publikováno v:
American Journal of Kidney Diseases, 62(4), 779-788. W B SAUNDERS CO-ELSEVIER INC
Background: Patients with thrice-weekly hemodialysis have higher predialysis weights and ultrafiltration rates at the first compared with subsequent dialysis sessions of the week. We hypothesized that these variations in weight and ultrafiltration ra
Autor:
Paul E. de Jong, Solmaz Assa, Stephan J. L. Bakker, Anneke C. Muller Kobold, Adriaan A. Voors, Ron T. Gansevoort, Casper F. M. Franssen, Ralf Westerhuis
Publikováno v:
Clinical Research in Cardiology, 102(6), 439-445. SPRINGER HEIDELBERG
Previous studies using conventional cTnI assays reported conflicting results on the evolution of cTnI levels during hemodialysis. The determinants and prognostic significance of changes in cTnI during hemodialysis are presently unknown. The aim of th